Cited by 125Retinal Diseases and TreatmentsOcular Diseases and Behçet’s SyndromeRetinal Imaging and Analysis

Circulating anti-retinal antibodies as immune markers in age-related macular degeneration

Patel, Nishal, Ohbayashi, Masahara, Nugent, Alex K., Ramchand, Kanchan, Toda, Masako, Chau, Kai‐Yin, Bunce, Catey, Webster, Andrew +3 more·2005·Immunology

Abstract

Age-related macular maculopathy (ARM) and age-related macular degeneration (AMD) are the leading causes of blindness in the Western world. Despite the magnitude of this clinical problem, very little is known about the pathogenesis of the disease. In this study, we analysed the sera (using indirect immunohistochemistry and Western blot analysis) from a very large cohort of such patients and normal age-matched controls to detect circulating anti-retinal antibodies. Patients with bilateral drusen (n = 64) and with chorioretinal neovascularization (CNV) (n = 51) were recruited in addition to age-matched control subjects (n = 39). The sera were analysed for anti-retinal immunoglobulins on retinal sections. The data were then correlated with the clinical features graded according to the International Classification and Grading System of ARM and AMD. The sera of patients with drusen (93.75%) and CNV (82.27%) were found to have a significantly (P = 0.02) higher titre of autoantibodies to the retina in comparison with controls (8.69%), indicating significant evidence of involvement of the immune process in early stages of AMD. Subsequent statistical analysis of the drusen group showed significant progressive staining (P = 0.0009) in the nuclei layers from early to late stages of ARM. Western blotting confirmed the presence of anti-retinal immunoglobulins to retinal antigens. As anti-retinal immunoglobulins are present in patients with bilateral drusen and exudative AMD, these antibodies could play a significant role in the pathogenesis of AMD. Whilst we do not have evidence that these antibodies precede disease onset, the possibility that their presence might contribute to disease progression needs to be investigated. Finally, the eventual identification of the target antigens detected by these antibodies may permit the future development of new diagnostic methods for ARM and AMD.

Integrity signals

Registry

Crossref · 10.1111/j.1365-2567.2005.02173.x

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Patel, N., Ohbayashi, M., Nugent, A. K., Ramchand, K., Toda, M., Chau, K., Bunce, C., Webster, A., Bird, A. C., Ono, S. J., & Chong, V.
Affiliations
  • King's College Hospital (GB)
  • University College London (GB)
Corresponding author
Ono, Santa Jeremy
Venue
Immunology
Publisher
Wiley
Published
2005-06-09
Volume
115
Issue
3
Pages
422-430
ISSN
  • 0019-2805 (ISSN-L)
  • 1365-2567
OpenAlex
W2157100733
Cited by
125
References
32
Citations by year
2026: 3 · 2025: 6 · 2024: 3 · 2023: 6 · 2022: 6 · 2021: 5 · 2020: 4 · 2019: 4 · 2018: 5 · 2017: 11 · 2016: 6 · 2015: 8 · 2014: 8 · 2013: 9 · 2012: 7
FWCI
4.59
Type
journal article
Language
en
Open access
closed
Locations
  • Immunology (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
Keywords
age-related macular degeneration, antiretinal antibodies, autoantibodies, drusen, choroidal neovascularization, retinal antigens, immunological markers, pathogenesis, disease progression, diagnostic biomarkers
MeSH terms
Aged, Antigens, Autoantibodies, Cells, Cultured, Female, HeLa Cells, Humans, Immunoglobulins, Immunohistochemistry, Macular Degeneration, Male, Middle Aged, Pigment Epithelium of Eye, Retina, Cohort Studies, Biomarkers, Retinal Drusen, Retinal Neovascularization, Microscopy, Confocal, Jurkat Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review